BELLOSTA, STEFANO
BELLOSTA, STEFANO
Dipartimento di Scienze Farmacologiche e Biomolecolari
27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells
1993 S. Bellosta, A. Corsini, F. Bernini, A. Granata, G. Didoni, M. Mazzotti, R. Fumagalli
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate
2006 S. Bellosta, M. Dell'Agli, L. Rizzi, G.V. Galli, M. Canavesi, F. Rota, R. Parente, E. Bosisio, S. Romeo
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate
2006 S. Bellosta, M. Dell'Agli, L. Rizzi, G.V. Galli, M. Canavesi, F. Rota, R. Parente, E. Bosisio, S. Romeo
A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate
2005 M. Dell'Agli, S. Bellosta, L. Rizzi, G.V. Galli, M. Canavesi, F. Rota, R. Parente, E. Bosisio, S. Romeo
ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading
2017 S. Castiglioni, M. Monti, A. Vettore, L. Arnaboldi, M. Canavesi, A. Corsini, S. Bellosta
ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading
2017 S. Castiglioni, M. Monti, L. Arnaboldi, M. Canavesi, G. Ainis Buscherini, L. Calabresi, A. Corsini, S. Bellosta
ABCA1 and HDL3 are Required to Modulate Smooth Muscle Cells Transdifferentiation in a Myocardin-miR143/145-Dependent Process
2016 S. Castiglioni, L. Arnaboldi, A. Vettore, L. Calabresi, A. Corsini, S. Bellosta
Angiogenesis inhibition with novel compounds targeting the key glycolytic enzyme PFKFB3
2018 A. Abdali, A. Corsini, D. Baci, C. De Dominicis, M. Zanda, M.L. Gelmi, S. Bellosta
Antiatherosclerotic activities of mibefradil in cell culture
1997 F. Bernini, M. Canavesi, S. Bellosta, N. Ferri, A. Palmitano, E. Bernardini, R. Fumagalli, A. Corsini
Aortic gene expression profiles show how ApoA-I levels modulate inflammation, lysosomal activity, and sphingolipid metabolism in murine atherosclerosis
2021 M. Busnelli, S. Manzini, M. Chiara, A. Colombo, F. Fontana, R. Oleari, F. Poti, D. Horner, S. Bellosta, G. Chiesa
Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease
1995 R.W. Mahley, B.P. Nathan, S. Bellosta, R.E. Pitas
Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factors
2022 L. Arnaboldi, A. Corsini, S. Bellosta
Best practice--ongoing polemics
1999 S. Bellosta, R. Paoletti
Biochemical and mechanical properties of intraluminal thrombus from human abdominal aortic aneurysm
2008 R. Ballerio, F. Boschetti, R. Spirito, S. Bellosta, A. De Francesco, M. Canavesi, E. Di Martino, E. Tremoli, M. Camera
Biodegradable nanoparticles for restenosis following PTA: a feasibility study
2017 F. Selmin, G. Magri, S. Bellosta, S. Castiglioni, V. Tolva, F. Puoci, F. Cilurzo
Caffeic Acid Grafted PLGA as a Novel Material for the Design of Fluvastatin Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia
2022 S. Bellosta, F. Selmin, G. Magri, S. Castiglioni, P. Procacci, P. Sartori, E. Scarpa, V. Tolva, C. Rossi, F. Puoci, L. Rizzello, F. Cilurzo
Calcium antagonists and cholesteryl ester metabolism in macrophages
1991 F. Bernini, S. Bellosta, G. Didoni, R. Fumagalli
Cardioprotective properties of olive oil-derived polyphenols
1997 F. Visioli, S. Bellosta, C. Galli
Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia
1999 G. Zuliani, M. Arca, A. Signore, G. Bader, S. Fazio, M. Chianelli, S. Bellosta, F. Campagna, A. Montali, M. Maioli, A. Pacifico, G. Ricci, R. Fellin
Cholesterol : its regulation and role in central nervous system disorders
2012 M. Orth, S. Bellosta